Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NutriBand (NTRB) Research & Development (2021 - 2025)

NutriBand (NTRB) has disclosed Research & Development for 5 consecutive years, with $457113.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 48.1% to $457113.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Oct 2025, down 31.31% year-over-year, with the annual reading at $3.1 million for FY2025, 59.1% up from the prior year.
  • Research & Development hit $457113.0 in Q4 2025 for NutriBand, down from $562554.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $974535.0 in Q2 2024 to a low of $117814.0 in Q2 2022.
  • Historically, Research & Development has averaged $480956.6 across 5 years, with a median of $457113.0 in 2025.
  • Biggest five-year swings in Research & Development: skyrocketed 239.88% in 2023 and later plummeted 48.1% in 2025.
  • Year by year, Research & Development stood at $161000.0 in 2021, then surged by 80.57% to $290718.0 in 2022, then soared by 89.7% to $551503.0 in 2023, then soared by 59.7% to $880768.0 in 2024, then tumbled by 48.1% to $457113.0 in 2025.
  • Business Quant data shows Research & Development for NTRB at $457113.0 in Q4 2025, $562554.0 in Q3 2025, and $683426.0 in Q2 2025.